- Home
- NEOG vs DYN Comparison
NEOG vs DYN Comparison
Compare NEOG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOG
- DYN
- Stock Information
- Founded
- NEOG 1981
- DYN 1984
- Country
- NEOG United States
- DYN United States
- Employees
- NEOG N/A
- DYN N/A
- Industry
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DYN Medicinal Chemicals and Botanical Products
- Sector
- NEOG Health Care
- DYN Health Care
- Exchange
- NEOG Nasdaq
- DYN Nasdaq
- Market Cap
- NEOG 1.2B
- DYN 1.4B
- IPO Year
- NEOG 1989
- DYN 2020
- Fundamental
- Price
- NEOG $4.94
- DYN $10.32
- Analyst Decision
- NEOG Buy
- DYN Strong Buy
- Analyst Count
- NEOG 2
- DYN 14
- Target Price
- NEOG $9.00
- DYN $44.57
- AVG Volume (30 Days)
- NEOG 5.1M
- DYN 2.5M
- Earning Date
- NEOG 07-29-2025
- DYN 08-11-2025
- Dividend Yield
- NEOG N/A
- DYN N/A
- EPS Growth
- NEOG N/A
- DYN N/A
- EPS
- NEOG N/A
- DYN N/A
- Revenue
- NEOG $905,996,000.00
- DYN N/A
- Revenue This Year
- NEOG N/A
- DYN N/A
- Revenue Next Year
- NEOG $0.48
- DYN N/A
- P/E Ratio
- NEOG N/A
- DYN N/A
- Revenue Growth
- NEOG N/A
- DYN N/A
- 52 Week Low
- NEOG $3.87
- DYN $6.36
- 52 Week High
- NEOG $18.58
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- NEOG 36.96
- DYN 34.25
- Support Level
- NEOG $5.44
- DYN $10.56
- Resistance Level
- NEOG $5.72
- DYN $15.23
- Average True Range (ATR)
- NEOG 0.40
- DYN 1.01
- MACD
- NEOG -0.05
- DYN -0.47
- Stochastic Oscillator
- NEOG 26.11
- DYN 4.10
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.